Menu

Indications of Vuity Eye Drops

Author: Medicalhalo
Release time: 2025-10-19 11:44:20

Vuity eye drops are the first prescription eye drops developed specifically for presbyopia (presbyopia), providing an innovative drug treatment option for people over the age of 40. Its main ingredient, pilocarpine hydrochloride, improves near vision through a unique pharmacological mechanism, avoiding the inconvenience of traditional reading glasses. This article will focus on analyzing the core indications, principle of action and usage restrictions of this drug to help readers fully understand this new option for ophthalmic treatment.

Indications of Vuity Eye Drops

It has a clear scope of clinical application, and its indications have been verified by rigorous clinical trials and mainly target specific vision problems.

Adult Presbyopia Treatment

Vuity eye drops are specifically approved to treat adult presbyopia, commonly known as presbyopia. Clinical data shows that patients aged 40-55 years old have the most significant improvement in near vision after use, with an average improvement of more than 3 lines on the visual acuity chart.

Near vision impairment

It is especially suitable for reading difficulties at close range caused by the decrease in the elasticity of the lens, including watching mobile phones, reading, and using computers. It takes effect within 1 hour after use and lasts for 6-10 hours, meeting daily eye needs.

Temporary vision correction

Provides a temporary alternative to optical correction, suitable for those who do not want to wear reading glasses or who need to temporarily improve their vision. The effect is reversible and does not affect the choice of other subsequent treatments.

These indications make Vuity eye drops an important supplement in the field of presbyopia treatment, filling the gap in drug correction.

Efficacy and role of Vuity eye drops

Vuity eye drops produce therapeutic effects through a specific pharmacological mechanism, and its action characteristics are essentially different from traditional optical correction.

Pupillary adjustment mechanism

The main ingredient pilocarpine hydrochloride stimulates the muscarinic receptors of the iris sphincter, producing a pupil constriction effect. This "pinhole effect" increases depth of field and improves close-range focusing capabilities.

Ciliary muscle effect

Partially activates the M receptors of the ciliary muscle to enhance the regulation ability. This dual mechanism of action makes it more effective than simple miotic drugs, and the vision improvement is more obvious.

Fast-acting characteristics

Visual improvement can be detected 30 minutes after eye drops, and the best effect is achieved in 1-2 hours. This rapid-acting characteristic makes it particularly suitable for sudden close eye needs.

Understanding these action characteristics can help patients reasonably anticipate treatment effects and choose the best timing for medication.

Contraindications of Vuity Eye Drops

Although Vuity Eye Drops are safe, they need to be banned or used with caution in some cases to avoid serious adverse reactions.

Absolute contraindications

It is prohibited for those allergic to pilocarpine hydrochloride or any excipients. It is prohibited to use it during the active stage of eye inflammation such as acute iridocyclitis and acute conjunctivitis, as it may aggravate the condition.

Relatively contraindicated groups

Patients with severe retinopathy need to be carefully evaluated, especially those with risk of retinal detachment. Patients with poorly controlled glaucoma should be used with intraocular pressure monitoring.

Special restrictions

Workers who drive at night or work in low-light environments need to pay special attention, as pupil constriction may lead to decreased dark vision. Those engaged in precision operations should evaluate the impact of fluctuations in vision on their work.

Patients should take the medication under the guidance of a professional ophthalmologist and strictly follow these contraindications.

[ 免责声明 ]  本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。